• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Altasciences Contributes to Vibegron Approval

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

    Pfizer Selects Seven Bridges to Support RNA Sequencing Data

    ACG Launches ACG Laboratories

    Glatt and Aprecia Enter 3D-Printing Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

    ACG Launches ACG Laboratories

    Glatt and Aprecia Enter 3D-Printing Collaboration

    Catalent Acquires Delphi Genetics

    Almac Group Completes $7M R&D Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre

    AARDEX Group Partners with Pill Connect

    Phillips-Medsize and Subcuject Collaborate
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Altasciences Contributes to Vibegron Approval

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

    Pfizer Selects Seven Bridges to Support RNA Sequencing Data

    ACG Launches ACG Laboratories
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene

    Alcami

    Reed-Lane

    Aphena Pharma Solutions

    test company saurabh
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Alcami

    Syngene

    Baxter BioPharma Solutions

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Pharmaceutical Packaging Market Report

    Key factors influencing the $70B market, overcoming rising costs, and opportunities on the horizon.

    Pharmaceutical Packaging Market Report
    Related CONTENT
    • Legacy Pharma Solutions
    • PCI Pharma Services
    • Catalent Pharma Solutions
    • Regis Custom Pharma
    • Aptar CSP Technologies
    Kristin Brooks, Managing Editor, Contract Pharma06.13.19
    The global pharmaceutical packaging market was valued at approximately $71.0 billion in 2018, and is projected to grow at a CAGR of nearly 6% during 2019-20291, according to new research by Future Market Insights, while Research and Markets say it will reach $149.3 billion by 2026, growing at an impressive CAGR of 8.75% during the 2017-2026 period.2 The dynamics behind these soaring numbers are growth in emerging markets, such as India, China, Brazil, Russia, and Turkey, and growing demand for drug delivery devices and blister packaging.

    Pharmaceutical Packaging helps to protect medicines from contamination, damage, degradation, and counterfeiting, as well as helps to extend product shelf life. Drug manufacturers are subject to international regulatory compliance and packaging plays a vital role in the drug supply chain process.

    Growth in the pharmaceutical packaging market, which includes: plastic bottles, parenteral containers, blister packaging, specialty bags, closures, labels, and other products, is attributed to increased R&D, generics, innovative packaging materials, and increased outsourcing to contract packagers. However, increasing packaging costs due to stringent regulations and anti-counterfeiting measures are impacting the full growth potential of the market.

    According to Research and Markets, the plastic bottle segment is among the largest growing sector, attributed to easy production, prevalence and favor in the pharmaceutical industry, and the protection it provides from various environmental conditions. Also, influenced by new and complex biologics, primary pharmaceutical packaging is experiencing rapid growth, and this sector represents a major opportunity for growth in the packaging market.

    By geography, North America maintains a substantial market share due to the increase in the number of new product launches with specialized packaging needs in this region, according to Research and Markets. Also, increased outsourcing of pharmaceutical manufacturing to emerging markets is expected to open new growth opportunities.

    Market Trends
    Packaging products are trending toward those that aid in patient compliance and are eco-friendly. A drug’s efficacy relies on a patient taking their medicines exactly as prescribed, and compliance continues to be a priority for packaging solutions. Technology is playing a key role in advancing compliance as packaging can now be connected to phones and other devices in an effort to enhance patient knowledge and adherence. Packaging that needs to be convenient as well as meet all of the previously mentioned criteria, requires innovative solutions. 

    Craig Voellmicke, vice president of business development for Aptar CSP Technologies said, “Accomplishing patient compliance is a goal that is typically best suited to blister packaging. However, as more and more drugs continue to require enhanced protection against moisture, oxygen and other gases, a major challenge can be that blisters, while offering unit-dose-level protection, traditionally haven’t had absorptive properties. In other words, you couldn’t just pop in a desiccant as you could with a bottle or vial.”

    Aptar CSP Technologies’ Activ-Blister solutions are designed to help control the internal atmosphere of individual blister cavities, allowing for improved product performance and enhanced shelf life. It offers moisture, oxygen and combination absorption, and the technology can be applied without the use of adhesives or changes to the existing footprint of a packaging line, according to Mr. Voellmicke.

    With a growing focus on sustainable products, there is an emphasis on environmentally friendly designs and materials used for pharmaceutical packaging. Packaging sourced from more sustainable materials, and less of it in general, is the goal. However, for the pharmaceutical industry, this challenge is even greater as the industry is subject to government safety regulations, patient compliance, unit-dose control, combating counterfeits, and providing child-resistant packaging.

    Reid Lederer, president of Pharma Packaging Solutions, said, “We have seen more interest in sustainable packaging choices as customers are considering environmental impact as one feature of their packaging choice. As a result we have expanded our offerings in this category.” For example, one of Pharma Packaging Solutions customers is packaging a medication based on sodium bicarbonate in gable top cartons, as opposed to plastic.

    Producing recycled paper creates 74% less air pollution and 35% less water pollution than producing paper from virgin fibers,3 according to the Carton Council, a group of carton packaging manufacturers united to grow carton recycling in the U.S. Moreover, lightweight packaging requires less energy to ship than heavier material and carton recycling is available in nearly all of the top 100 U.S. markets. 

    Key Factors Influencing Packaging
    Today’s pharmaceutical packaging is heavily influenced by cold chain needs, schedule II systems (narcotics), patient dosing regimens, and regulatory compliance, and pharma and biopharma companies require advanced packaging solutions in these areas.

    Aptar CSP’s Craig Voellmicke said, “Pharma companies are seeking novel self-administered treatments that not only protect the product through the point of care, but also enable ease of use / proper use. Per our niche, this could mean putting a prescription in a calendarized blister package whose film is desiccated on a per-dose basis, where before that technology simply wasn’t available. It’s a key combination of product protection and patient adherence, ease of use and “trackability” –meaning a calendarized blister pack can let a patient know that he took yesterday’s pill but hasn’t yet taken today’s pill.”

    According to Gene Dul, president of Schreiner MediPharm U.S., “Important factors influencing pharmaceutical packaging today are supply chain integrity, patient centricity, user convenience, digitalization and sustainability. In addition, there are special packaging needs for highly sensitive drugs such as biopharmaceuticals or biosimilars, and growing segmentation trends demand small batches and a wide variety of sorts with short delivery times. Pharmaceutical packaging suppliers have to address these requirements and provide tailored solutions for each application, while ensuring smooth processability at the pharmaceutical manufacturer.”

    Additionally, regulatory initiatives have prompted significant change in the industry for packaging. For example, Health Canada recently introduced Plain Language Labelling (PLL) Regulations that aim to improve the safe and effective use of OTC medications by making outer packaging easier to read and understand, for which all brands selling to the Canadian market must comply. Nic Hunt, senior vice president, Strategic Initiatives at Jones Packaging Inc. said, “At Jones, we’ve been heavily focused on responding to regulatory shifts in Canada for OTC drug packaging. This presents a major challenge to the pharmaceutical supply chain, given significantly more information is required on outer packaging. In turn, packaging formats must change significantly to accommodate regulations, while minimizing changes to the packaged product.” He noted that full compliance for OTC products on retail shelves is required by June 2021 and similar regulations for natural health product packaging are soon to follow.

    Pharma and biopharma needs have changed over the years. According to Reid Lederer of Pharma Packaging Solutions, in the 24 years the company has been providing pharmaceutical packaging services, there have been a sea change of requests. Mr. Lederer said, “It boils down to this: more environmentally friendly and protective packaging, a packaging partner who can complete complex technical requirements, and partnering strategically so that compliance and cost goals can be met.”

    Curbing Escalating Costs
    All of these packaging trends come at a cost, which is quickly escalating. Stringent regulations and anti-counterfeiting efforts are at the heart of these costs. For contract packagers, cost is always a challenge for clients, and even more so now as pharmaceutical companies face pricing pressures. Contract Packagers are charged with finding cost efficiencies from the materials purchased, to deciding which packaging line to run on.      

    According to David Manis, marketing and sales associate for Reed-Lane, “Pharmaceutical companies are placing a greater emphasis on packaging costs. At the same time they are becoming more hands off and outsourcing all functions and responsibility. They are looking for packaging specification development, serialization, cold storage, as well as finding efficiencies throughout the process. Packagers are also seeing an increase in the cost of components. This makes it more important than ever for packagers to rely on their experience to offer alternatives that create a high quality product at an acceptable price, and to efficiently plan component and material purchases.”

    Mr. Manis added, “Unfortunately regulations are what they are and can’t be avoided and can often lead to increased packaging costs. Hence, it is the packager’s responsibility to stay abreast of the regulations and the technology employed to implement these regulations. Often significant capital investment is required to meet these regulations and this cost is usually going to be incorporated into the final piece price. It is hoped that efficiencies can be realized downstream at some point so as to minimize cost pressures.” Contract packagers can leverage their knowledge and experience to help clients find cost efficiencies based on the size of the package, volumes ordered, and packaging configuration.

    While the cost of anti-counterfeiting measures represents a significant investment for pharma and biopharma companies, the impact of having their products tampered with can potentially be an even greater threat. Gene Dul of Schreiner MediPharm U.S. said, “Depending on the threat scenario and the respective regulations, anti-counterfeiting efforts do have a cost impact on pharmaceutical packaging. However, pharmaceutical manufacturers have to consider the implications possible counterfeits of their products would have. Counterfeiting not only puts the safety of patients at risk, but also the reputation of the pharmaceutical company that could suffer big sales losses as a result of pirated products. Packaging or labeling suppliers with an extensive know-how and consulting expertise, together with the pharmaceutical customer, can help find the optimal security solution for specific supply chain challenges.” 

    Opportunities
    The tremendous growth in biologics and cold chain, the ever growing concern for supply chain security, and patient adherence and administration represent huge growth areas and opportunities in the packaging market.

    According to Mr. Manis of Reed-Lane, “We see the most opportunity in packaging for the biologic market. With the continued rise in the demand for cold chain storage, more customers are looking for packagers that have cold chain services. For a contract packager like Reed-Lane, we use cold storage to enhance our service offering for labeling and kitting of vials and syringes, and serialization of these kits.” The company recently installed a new packaging suite located next to its cold storage unit, which is dedicated to labeling and kitting vials and syringes. The new suite aims to minimize excursion time for cold chain products.

    “Considering the market trends, we see great opportunities to meet pharmaceutical packaging needs with highly functional labels addressing today’s and future challenges,” said Gene Dul of Schreiner MediPharm U.S. “Customized labels with integrated, multi-level authentication features can help to secure the pharmaceutical manufacturer’s supply chain, allowing verification by several stakeholders, including the end-user as well as informed experts. Tamper protection labels include closure seals for cardboard boxes as well as tamper-evident security solutions for clear first-opening indication of vials and syringes.”

    In the area patient compliance, Gene Dul added, “For patient centricity and growing self-medication demand for medicines that are easy and convenient to administer, Smart labels with an integrated NFC chip can add value to the primary container or injection device while supporting the digitalization trend. A label-integrated NFC chip enables diverse interactive applications to optimally assist the patient during self-medication. Via a smartphone the patient can easily access additional product information, demo videos or special apps, or perform mobile product authentication.”

    There are opportunities across all packaging segments, according to Mr. Hunt of Jones Packaging, the challenge for both pharmaceutical and packaging organizations is delivering on increasing functional requirements, from informing and protecting, to managing the dispensing of the products. “We have focused on developing a platform that includes proven, multi-panel folding cartons and multi-panel pressure-sensitive labels that maximize branding, minimize retail shelf footprints, ensure packaging line performance and are fully customized to our clients’ needs,” said Mr. Hunt.

    On the horizon, perhaps nanotechnology, the science and engineering at nanoscale, which is about 1 to 100 nanometers, can offer the potential to address eco-friendly ideals and allow for more innovative packaging solutions. Improved barrier properties in plastics and enhanced functionality for nanotechnology should also help facilitate the growth of the pharmaceutical packaging market. 

    References:
    1. April 2019, Pharmaceutical Packaging Market: Global Industry Analysis 2014-2018 and opportunity Assessment 2019-2029. https://www.futuremarketinsights.com/reports/pharmaceutical-packaging-market
    2. August 2018, Pharmaceutical Packaging - Global Market Outlook (2017 2026). https://www.researchandmarkets.com/research/4x4g92/149_billion?w=5
    3. https://www.recyclecartons.com/learn/#faq
    Related Searches
    • pharmaceutical packaging
    • nanotechnology
    • brazil
    • it
    Suggested For You
    Legacy Pharma Solutions Legacy Pharma Solutions
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Regis Custom Pharma Regis Custom Pharma
    Aptar CSP Technologies Aptar CSP Technologies
    Softweb Solutions Softweb Solutions
    Reed-Lane Reed-Lane
    Vetio Animal Health Vetio Animal Health
    Adare Pharma Solutions Adare Pharma Solutions
    Growth in Biologics and Maintaining Patient Satisfaction  Growth in Biologics and Maintaining Patient Satisfaction
    Reed-Lane Opens Cold Chain Room for Vial and Ampoule Kitting Reed-Lane Opens Cold Chain Room for Vial and Ampoule Kitting
    Schreiner MediPharm Introduces Product for Double Tamper Protection Schreiner MediPharm Introduces Product for Double Tamper Protection
    Pharmaceutical Packaging Marketing Trends Pharmaceutical Packaging Marketing Trends
    Contract Packaging Trends Contract Packaging Trends
    Lonza Launches Capsugel Zephyr DPI Portfolio Lonza Launches Capsugel Zephyr DPI Portfolio

    Related Features

    • Solid Dosage/Creams/Ointments
      High Drug Loading Amorphous Solid Dispersions

      High Drug Loading Amorphous Solid Dispersions

      A Novel Tablet Architecture for Amorphous Solid Dispersions to Achieve High Drug Loadings
      Deanna Mudie and Aaron Stewart, Lonza 01.27.21

    • Parenterals
      Parenteral Drug Delivery Trends

      Parenteral Drug Delivery Trends

      A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.
      Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

    • Selecting the Right Outsourcing Model for Emerging Biotech

      Selecting the Right Outsourcing Model for Emerging Biotech

      Flexible outsourcing models help drive quality, control costs and enable better efficiencies and faster delivery.
      Timothy King and Elisha Talley-Roithner, PPD 01.27.21


    • Drug Delivery
      Inhaled Drug Delivery Technology

      Inhaled Drug Delivery Technology

      The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 01.27.21

    • Biologics, Proteins, Vaccines
      The Future of Biologics: Accelerating Production, Reducing Costs

      The Future of Biologics: Accelerating Production, Reducing Costs

      Yeast-based gene expression offers pharma the yield and efficiencies it needs to make pandemic-stopping vaccines faster and more economical.
      Mark Emalfarb, Dyadic 01.27.21

    • Analytical Services | Information Technology | Laboratory Testing
      Business Intelligence For (and From) the Lab

      Business Intelligence For (and From) the Lab

      How a digital ecosystem can harness the most data-rich environment in the CDMO.
      Bob Voelkner, VP Sales and Marketing, LabVantage 01.27.21


    • Communicating Your Contracting Priorities to Your Drug Company Customers

      Communicating Your Contracting Priorities to Your Drug Company Customers

      A discussion with Perrigo’s senior legal counsel, Susan Fyan, about issues that arise in very fact-specific contract negotiations between CDMOs and sponsors.
      Stephen Sayre, Dykema 01.27.21

    • COVID-19 Impact Report

      COVID-19 Impact Report

      Leaders across the pharmaceutical contract services industry reflect on the impact of COVID-19 in 2020, and what to expect in 2021.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Biologics, Proteins, Vaccines | Regulatory Affairs
      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to “normalcy.”
      Chad Landmon, Michelle Divelbiss and Alex Alfano, Attorneys - Axinn, Veltrop & Harkrider LLP 01.27.21


    • Excipients
      Bye-Bye China?

      Bye-Bye China?

      Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.
      Michele Jermini and Enrico Polastro 11.17.20

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20


    • The Single-Use Mixing Landscape: Evaluating Your Options

      The Single-Use Mixing Landscape: Evaluating Your Options

      Adoption of single-use technologies has increased markedly in recent years and will continue to grow.
      Mark A. Sitcoske, Founder & CEO, High Purity New England 11.17.20

    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
      Tim Wright, Editor, Contract Pharma 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    Trending
    • Century Therapeutics Significantly Expands Capabilities
    • Catalent Acquires Delphi Genetics
    • Sanofi And Translate Bio Expand Vaccine Collaboration
    • RotaChrom Technologies Partners With Cyclolab
    • Inside A Vaccine Trial
    Breaking News
    • Altasciences Contributes to Vibegron Approval
    • Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    • Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    • ACG Launches ACG Laboratories
    • Glatt and Aprecia Enter 3D-Printing Collaboration
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Coatings World

    Latest Breaking News From Coatings World

    Hempel Launches Sustainability Framework: Futureproof
    ChemQuest Hires Rich Gibson
    New Increase in Kynar Fluoropolymer Capacities at Arkema's Chinese Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences
    Abiomed Leader Michael Minogue Named AdvaMed Board Chairman
    TransEnterix Changes Name to Asensus Surgical
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Altasciences Contributes to Vibegron Approval
    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Madison Reed Raises $52 Million in Financing Round
    The Estée Lauder Companies Closes Becca Cosmetics
    Afro Sheen Launches New Brand Initiatives
    Happi

    Latest Breaking News From Happi

    PBA Opposes House Bill 2325 in West Virginia
    J.R. Watkins Tackles Pain with New Lines
    RB Launches Vanish Miracle
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Lowe-Martin Adds 2 KODAK NEXFINITY Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eaglewood Technologies debuts new anilox cleaning system
    INX International and VerifyMe sign supply agreement
    Soma partners with DTM Flexo Services
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    H&V Announces Price Increase
    Fiber Bond VE3 Technology Inactivates SARS-CoV-2 in HVAC Filtration Systems
    Citizens Provides $325 Million Senior Credit Facility to Nice-Pak
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    NuVasive Nabs Simplify Medical for $150M
    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    Nexus Spine Implants for Use in Spinal Surgeries Become Available
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    RFID Locks Market to Reach $9.93 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login